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BIO 4020-02: Current Literature: Biology of Regeneration 
Fall 2014 
Dr. Labib Rouhana 
 
Dr. Rouhana notes that students were challenged to write a scientific 
proposal centered in the study of regenerative organisms. This 
proposal describes experiments designed to identify genes involved 
in protecting an organism with negligible senescence from tumor 
formation. Ms. Dorsten was able to formulate a proposal of 
outstanding quality with regards to both literary competency and 
scientific creativity. Her work is written in clear and concise “stand-
alone” statements with smooth transitions within paragraphs and 
throughout the proposal. Exemplary attention to detail is evident by 
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BACKGROUND 
Planarians, flatworms widely known for their incredible regenerative 
capabilities, are able to restore an entire organism from even a small 
fragment of tissue. This ability to regenerate is attributed solely to 
neoblasts, pluripotent adult stem cells located throughout the 
parenchyma of the animal (Newmark and Sanchez Alvarado, 2002). 
Neoblasts are stimulated to migrate and proliferate in times of injury 
(Guedelhoefer and Sanchez Alvarado, 2012). Lethally irradiated 
planarians (devoid of stem cells and therefore unable to regenerate) 
can restore regenerative capability through transplantation of a single 
neoblast from a healthy planarian (Wagner et al., 2011). Many studies 
have concluded that the population of neoblasts is not homogenous 
(Scimone et al., 2014), and there are different responses to different 
injury types. Wenemoser and Reddien (2012) observed a body-wide 
increase in mitotic activity, such as cell division and migration, with 
any injury. 
 
A second peak was localized at the wound site and observed only in 
those planarians where tissue was lost during injury. Planarians have 
also been found to be equipped to handle not only injury but 
microorganisms as well. Various bacterial strains that are pathogenic 
to humans were cleared from their tissue, including Legionella 
pneumophila and Mycobacterium tuberculosis among others (Abnave et al., 
2014). Through RNA sequencing, the researchers were able to 
identify a specific gene utilized by the planarian during clearance of 
bacteria from tissues (Abnave et al., 2014). Since planarians are able 
to resist infection of bacterial agents and restore normal regeneration 
once the bacteria has been cleared (Abnave et al., 2014), questions 
involving the resistance to more serious diseases, such as cancer, 
follow. For example, would a planarian be able to recognize 
cancerous cells, activate appropriate signaling pathways, and correctly 
execute the mechanisms needed to rid the animal of the 
abnormalities? 
 
Cancer, the second leading cause of death in the United States, 
accounts for 1 of every 4 deaths (American Cancer Society, 2014). In 
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simplest terms, cancer is an out-of-control division of abnormal cells 
(American Cancer Society, 2014). In many forms of cancer, the 
abnormal cells group together to form a tumor which can replace 
healthy tissue (American Cancer Society, 2014). Depending on where 
the tumor is located and how large it has grown, it can interrupt 
normal functioning of various organs and cause pain, weakness, 
and/or fever (American Cancer Society, 2014). Cancer can be caused 
by genetics along with a wide variety of activities including UV 
exposure and tobacco use (American Cancer Society, 2014). 
Planarians routinely employ above-average proliferation of neoblasts 
in response to changes in homeostasis. Therefore, planarians should 
theoretically be at a high risk of developing cancerous tumors. 
However, various studies have brought the concept of tumor 
suppression in regenerative animals to the surface and numerous 
genes involved have been identified (Pearson and Sanchez Alvarado, 




Initially, the goal of the proposed research is to confirm the presence 
of tumor-suppressing genes in planarians and determine how 
effective these genes are in suppressing tumor formation at varying 
levels of carcinogenic administration. The next goal is to determine 
whether or not silencing of these tumor-suppressing genes makes 
planarian more susceptible to the formation of tumors. This 
experiment will help to determine if mechanisms other than the 
previously found genes, such as p53 (Pearson and Sanchez Alvarado, 
2009), are involved in suppressing tumors in highly regenerative 
animals. Lastly, this research aspires to determine whether orthologs 
of these tumor-suppressing genes exist in humans. It can be 
hypothesized that planarians utilized in this experiment will display 
these previously found tumor-suppressing genes, silencing these 
genes will lead to increased risk of tumor formation, and these genes 
will be conserved in humans to some degree. Overall, the goal of this 
research is to attempt to develop new avenues for anti-cancer 
therapies for individuals at a high risk of developing cancer.  
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RESEARCH DESIGN 
In order to accomplish the first goal of confirming the presence of 
tumor-suppressing genes, an experiment composed of four different 
groups of the planarian Schmidtea mediterranea will be performed. 
 
Group 1 will be a control group of healthy, intact 
planarians that act as a baseline for all measurements taken. 
Group 2 will be intact planarians that are given one of 
three carcinogens, 3,4- dibenzpyrene, DDT, or 1,2:5,6-
dibenzanthracene (Schaeffer, 1993), in step-wise increases. 
The use of multiple carcinogens will assist in determining 
the changes in gene expression due to administration of a 
chemical versus changes in response to cancer. 
Group 3 will be planarians that are amputated and allowed 
to begin regeneration before administration of the same 
carcinogens as in the second group in step-wise increases 
to determine if the increased presence and proliferation of 
neoblasts affects gene expression. 
Group 4 will be planarians that are lethally irradiated and 
administered carcinogens in step-wise increases as in 
groups 2 and 3. 
 
This last group will be able to confirm or refute whether the presence 
of neoblasts affects tumor suppression. Since neoblasts are the only 
proliferative cells within planarians, it can be hypothesized that they 
are the main regulators of proliferation. Therefore, irradiated 
planarians are not expected to form tumors. 
 
A carcinogen is one of any number of agents that cause cancer by 
affecting the DNA of a cell (Encylopedia Britannica, 2014). Various 
compounds have been identified that induce tumor growth within 
planarians (Schaeffer, 1993), and these compounds can be 
administered through feeding or transdermal application. The 
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carcinogens used will be examined before administration in order to 
determine the mutation they will cause on the DNA of the planarian. 
Therefore, visualization of mutated DNA through DNA visualization 
software may be utilized. All planarians, except those in the control 
group, will be administered the same concentration of their 
respective carcinogen on day 1. The planarians will be given a 
sufficient amount of time for the carcinogen to mutate the DNA of a 
number of cells, and these cells will be allowed to replicate the DNA. 
At this time point, a subset of planarians from groups 2, 3, and 4 will 
be fixed and subjected to in situ hybridization for Smed-p53. If no 
DNA was mutated, and therefore no tumors can be formed, the 
process will be repeated with an increased concentration of 
carcinogens administered to the remaining planarians. This cycle will 
continue until a tumor is observed in each group. At each time point, 
a number of planarians will be subjected to RNA sequencing and the 
results will be compared against the baseline control group to 
determine the gene expression changes that occur with carcinogen 
administration. 
 
Once the genes involved in tumor suppression are evaluated through 
RNA sequencing, RNA interference (RNAi) will be performed to 
determine whether these genes are required for tumor suppression in 
planarians. Again, there will be a step-wise increase of carcinogenic 
administration to determine if the level of carcinogenic material 
affects the efficiency of these mechanisms. The same four groups 
and procedures will be used as above except that the genes found to 
be involved with tumor suppression in the previous results will be 
silenced in all four groups using RNA interference. Additional 
control RNAi groups will be utilized to act as a baseline to compare 
against the candidate gene RNAi and then to compare the extent of 
tumor formation. Again, in situ hybridization and RNA sequencing 
will be conducted on every planarian to determine at what time point 
and carcinogen concentration the presence of tumors emerges and 
the gene expression changes, respectively. 
 
ERIN DORSTEN BIO 4020 
Best Integrated Writing: Journal of Excellence  
in Integrated Writing Courses at Wright State 2015, Article 
#
5, pg. 6 
Lastly, the genes found with experimentation to be involved in tumor 
suppression will be fully sequenced, and online databases of human 
orthologs will be searched. These human orthologs will now serve as 




With the first experiment, healthy, intact planarians that received 
carcinogens would initially be expected to show signs of tumor 
suppression in the results. These signs would include little to no 
abnormal DNA shown with visualization software and an up-
regulation of genes involved in tumor suppression in the RNA 
sequencing of the planarians. Once the tumor suppression system is 
exhausted and cancerous cells form, abnormal DNA would be 
quantified with visualization software, but the expression of the 
tumor-suppressing genes may be either up- or down-regulated. Since 
cancers affect the DNA of dividing cells, and neoblasts are the only 
mitotically active cell within a planarian, it can be hypothesized that 
the distribution of cells with mutated DNA, before the formation of 
a tumor, will occur through neoblasts. The regenerating planarians 
administered carcinogens are expected to produce similar results. 
However, previous research has found a specific tumor-suppressing 
gene in planarians, Smed-p53 which is mainly expressed in newly made 
stem cell progeny (Pearson and Sanchez Alvarado, 2009). 
 
It can be expected that the results would be exaggerated with respect 
to that of group 2 due to increased neoblast population induced by 
amputation. It is anticipated that a more concentrated dose of 
carcinogen would be needed to induce tumor formation; therefore, a 
longer amount of time would pass in which no abnormal DNA 
would be seen. Also, the expression of the tumor suppression genes 
with RNA sequencing is expected to be higher relative to that of 
healthy, intact planarians in group 2. The irradiated planarians in 
group 4 are not expected to form tumors due to the absence of 
proliferative cells. It can be expected that an increase in proliferation 
would occur in all of the experimental groups with a knockdown of 
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the tumor-suppressing genes if no other mechanisms exist to ward 
off hyper-proliferation in planarians. A similar result was observed in 
an experiment conducted by Sanchez Alvarado (2012) in which RNA 
interference was used to inhibit activity of the tumor-suppressing 
gene, Smed-p53. Smedp53( RNAi) animals are expected to develop 
tumors not observed in normal control animals. Again, healthy, intact 
group 1 planarians would be used as a baseline for all of the results 
obtained from the experimental groups. Knockdown planarians from 
groups 2 and 3 are expected to show less effective tumor suppression 
than controls, and are expected to display an increase in abnormal 
DNA with lower concentrations of administered carcinogen. Again, 
due to the absence of neoblasts in the irradiated planarians of group 
4, they would not be expected to form tumors upon carcinogenic 
administration. 
 
The final stage of this research involves identification of human 
orthologs to established planarian tumor-suppressing genes. Previous 
research in planarians has shown that knock down of PTEN by RNA 
interference in planarians results in the presence of abnormal cells 
that behave similarly to cancerous cells in humans (Oviedo and 
Beane, 2009). The human PTEN homolog was found to be the most 
commonly mutated gene within cancer patients (Oviedo and Beane, 
2009). Therefore it can be expected that more human cancer gene 
orthologs will be found from this project, but the identity of the 
genes can only be determined by experimentation. 
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POTENTIAL PITFALLS/ALTERNATIVE APPROACHES 
With the first experiment it is possible that cancerous cells never 
actually aggregate into a tumor with increasing carcinogen 
administration. While this result would certainly lead to adjustments 
to the research, it would not be deleterious. This outcome would 
simply demonstrate superior effectiveness of the planarian’s 
mechanisms for tumor suppression. The up- or down-regulation of 
genes would still be obtained from RNA sequencing of planarians. 
This information would be sufficient for continuation into the 
second section of the research. 
 
Possible setbacks exist that may affect either the first or second 
portions of this research. The first setback is the possibility that the 
carcinogen could be unsuccessfully administered. In other words, the 
carcinogen is not given the opportunity, or is unable, to be 
incorporated into the cells. Therefore, tumor growth would never 
occur due to the lack of damaged DNA, which would then never 
replicate producing unnecessary cells also possessing damaged DNA. 
In order to lessen the likelihood of this event occurring, control 
experiments will be conducted before the start of the actual 
experimental protocol. The possibility of carcinogen ineffectiveness 
will be eliminated by testing administration of the carcinogen on a 
small group of planarians not involved in the experiment. As 
explained above, these planarians would be expected to form tumors 
upon carcinogenic being administered. If this group does not 
produce the expected results, a different method of administration 
will be used, such as soaking the planarians in the carcinogen. 
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POTENTIAL OF CANDIDATE AND HOST LABORATORY 
This research is to be conducted in the Howard Hughes Medical 
Institute at the University of Illinois at Urbana-Champaign. This lab 
frequently conducts research using S. mediterranea as a model 
organism and has all of the resources necessary to effectively perform 
the mechanisms described in this proposal. The candidate researcher 
displays advanced knowledge of the biological processes to be 
utilized in this research. The candidate scientist and supporting 
research staff are competent and thorough in their roles and work 




Planarians have the unique ability to regenerate and reproduce an 
incalculable number of times from stem cells that proliferate without 
tumor formation. The ultimate goal of this proposed research is to 
determine the existence of human orthologs of the genes responsible 
for tumor suppression in planarians. If this research is successful, a 
new avenue of possible anti-cancer therapies could result. For 
example, if genes susceptible to mutation in humans can be 
identified, it may be possible to create new therapies that strengthen 
the molecular make-up against mutations that commonly occur in the 
cancer. Obviously, more research is needed to determine whether or 
not a therapy based on this study is a possibility in the clinic. More 
experimentation would be necessary on vertebrate model systems, 
such as mice. However, if possible, such therapy (or therapies) could 
improve the quality of life of millions of individuals. Cancer is a 
devastating disease that was estimated by the American Cancer 
Society (2014) to affect 1,665,540 new patients and be responsible for 
585,720 deaths just this year. This number could be greatly reduced if 
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CLOSING 
The goal of this research is to utilize planarians as a model for cancer 
prevention in the human body. By using results from previous 
research and knowledge of the mechanisms associated with the 
regenerative capabilities of planarians, genes with specific functions 
can be identified and isolated. In this case, the target genes are 
involved in the planarian’s ability to suppress tumor formation in the 
face of frequent hyper-proliferation linked to wound healing and 
regeneration. In order to accomplish this goal, the planarian S. 
mediterranea will be subjected to administration of carcinogenic 
material and the resultant gene expression changes will be recorded. 
In hopes that the genes involved in suppressing tumors in planarians 
are conserved in humans, they will be compared to human genes 
using various online databases, such as NCBI and SmedGD. Overall, 
the results of this research hope to shed some light on new possible 
anti-cancer therapies for high-risk patients. With the potential of 
advancement of anti-cancer therapies in humans, the National 
Institutes of Health (NIH) should take this proposed research into 
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